8-17938861-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006197.4(PCM1):āc.464A>Gā(p.Asp155Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000353 in 1,613,758 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 33)
Exomes š: 0.000037 ( 0 hom. )
Consequence
PCM1
NM_006197.4 missense
NM_006197.4 missense
Scores
1
5
12
Clinical Significance
Conservation
PhyloP100: 5.81
Genes affected
PCM1 (HGNC:8727): (pericentriolar material 1) The protein encoded by this gene is a component of centriolar satellites, which are electron dense granules scattered around centrosomes. Inhibition studies show that this protein is essential for the correct localization of several centrosomal proteins, and for anchoring microtubules to the centrosome. Chromosomal aberrations involving this gene are associated with papillary thyroid carcinomas and a variety of hematological malignancies, including atypical chronic myeloid leukemia and T-cell lymphoma. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.091814846).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCM1 | NM_006197.4 | c.464A>G | p.Asp155Gly | missense_variant | 5/39 | ENST00000325083.13 | NP_006188.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCM1 | ENST00000325083.13 | c.464A>G | p.Asp155Gly | missense_variant | 5/39 | 1 | NM_006197.4 | ENSP00000327077.8 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152234Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152234
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000483 AC: 12AN: 248442Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134860
GnomAD3 exomes
AF:
AC:
12
AN:
248442
Hom.:
AF XY:
AC XY:
3
AN XY:
134860
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000370 AC: 54AN: 1461406Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 24AN XY: 727022
GnomAD4 exome
AF:
AC:
54
AN:
1461406
Hom.:
Cov.:
31
AF XY:
AC XY:
24
AN XY:
727022
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152352Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74506
GnomAD4 genome
AF:
AC:
3
AN:
152352
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
5
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.464A>G (p.D155G) alteration is located in exon 5 (coding exon 3) of the PCM1 gene. This alteration results from a A to G substitution at nucleotide position 464, causing the aspartic acid (D) at amino acid position 155 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D;D;D;D;.;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
N;.;D;D;D;N;N
REVEL
Benign
Sift
Uncertain
D;.;D;D;D;D;D
Sift4G
Benign
T;T;D;D;D;T;T
Polyphen
1.0
.;.;D;.;.;.;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0692);Gain of MoRF binding (P = 0.0692);Gain of MoRF binding (P = 0.0692);Gain of MoRF binding (P = 0.0692);Gain of MoRF binding (P = 0.0692);Gain of MoRF binding (P = 0.0692);Gain of MoRF binding (P = 0.0692);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at